Coldstream Capital Management Inc Kal Vista Pharmaceuticals, Inc. Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Kal Vista Pharmaceuticals, Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 69 shares of KALV stock, worth $890. This represents 0.0% of its overall portfolio holdings.
Number of Shares
69Holding current value
$890% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding KALV
# of Institutions
138Shares Held
54.3MCall Options Held
699KPut Options Held
36.6K-
Vr Adviser, LLC New York, NY6.25MShares$80.7 Million8.73% of portfolio
-
Suvretta Capital Management, LLC New York, NY4.91MShares$63.4 Million1.73% of portfolio
-
Tang Capital Management LLC San Diego, CA4.89MShares$63.2 Million3.11% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA4.89MShares$63.1 Million2.48% of portfolio
-
Vestal Point Capital, LP New York, NY4.77MShares$61.6 Million2.4% of portfolio
About KalVista Pharmaceuticals, Inc.
- Ticker KALV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,602,000
- Market Cap $318M
- Description
- KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...